Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 +0.51%57 PS Ratio is 1.09 as of Jul. 24, 2026, which is 14% above its 10-year median of 0.96. GuruFocus rates TSE:6029 with a GF Score™ of 57/100 and a GF Value™ of 円140.25 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Artra Group ranks better than 60.39% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Artra Group's share price is 円199.00.
Artra Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円182.53. Hence, Artra Group's PS Ratio for today is 1.09.
Good Sign:
Artra Group Corp stock PS Ratio (=0.53) is close to 1-year low of 0.53.
The historical rank and industry rank for Artra Group's PS Ratio or its related term are showing as below:
TSE:6029'
s PS Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.96 Max: 4.12
Current: 1.09
During the past 13 years, Artra Group's highest PS Ratio was 4.12. The lowest was 0.29. And the median was 0.96.
TSE:6029's PS Ratio is ranked better than 60.39% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.45
vs TSE:6029: 1.09
Artra Group Corp revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Artra Group was -7.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -7.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.00% per year.
During the past 13 years, Artra Group's highest 3-Year average Revenue per Share Growth Rate was 18.40% per year. The lowest was -13.50% per year. And the median was 8.30% per year.
Back to Basics: PS Ratio
Artra Group (TSE:6029) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Artra Group PS Ratio Related Terms
Artra Group PS Ratio Historical Data
* Premium members only.
The historical data trend for Artra Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Artra Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Artra Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Artra Group's Share Price of today is 円199.00. Artra Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円182.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Artra Group (TSE:6029) has a PS Ratio of 1.09 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Artra Group and its competitors. This is 14% above median its historical median of 0.96. Over the past decade, Artra Group's PS Ratio has ranged from 0.29 to 4.12. According to the industry distribution chart, Artra Group ranks #261 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 39.6%.
Is Artra Group's PS Ratio too high?
Artra Group's current PS Ratio of 1.09 is 14% above median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 4.12. The Healthcare Providers & Services industry median PS Ratio is 1.45. Artra Group's value of 1.09 is 24.8% below this industry median. Based on the distribution chart, Artra Group ranks #261 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Artra Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #261 out of 659 companies for PS Ratio. This puts Artra Group in the upper half of its industry. The industry median PS Ratio is 1.45. Artra Group's value of 1.09 is 24.8% below this benchmark. Historically, Artra Group's own PS Ratio has ranged from 0.29 to 4.12 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 1.45, Artra Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.45, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artra Group's current PS Ratio of 1.09 is 24.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current PS Ratio is 1.09, which is 14% above median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.25, compared to a current price of 円199.00 — trading 41.9% above its estimated fair value. The current PS Ratio is 1.09, which is 14% above median its 10-year median of 0.96 and 24.8% below the Healthcare Providers & Services industry median of 1.45. Artra Group's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Artra Group (TSE:6029), the current PS Ratio is 1.09 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円199.00 is trading 41.9% above its estimated GF Value™ of 円140.25.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
PS Ratio: 1.09 (14% above median its 10-year median of 0.96)
GF Value™: 円140.25 vs. price of 円199.00 (41.9% above fair value)
Industry Position: 24.8% below the Healthcare Providers & Services median (#261 of 659)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
57GF Score
Get the complete analysis for TSE:6029
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
